|
|
|
|
Research Article
|
|
Rapid Molecular Diagnosis for Candida species Using PCR-RFLP |
|
S.A. Ayatollahi Mousavi ,
E. Khalesi ,
G.H. Shahidi Bonjar ,
S. Aghighi ,
F. Sharifi
and
F. Aram
|
|
|
ABSTRACT
|
Rapid identification of Candida species in clinical laboratory is becoming increasingly important since the incidence of Candidiasis continues to rise as the hospital surveys show. Molecular techniques utilizing amplification of target DNA provide quick and precise methods for diagnosis and identification of Candida species. In this study, using universal primers, the ITS1-ITS4 region was amplified. The restriction enzyme MspI digests this region and was used to identify of C. albicans, C. glabrata, C. krusei, C. tropicalis and C. guilliermondii. Electrophoretically, ribosomal DNA of C. guilliermondii produced three bands whereas the other species gave two bands upon digestion. Accordingly these enzymes behave as valuable application tools in molecular diagnosis of Candida species in Candidiasis maladies and can be substituted with the classical diagnosis of the pathogen.
|
|
|
|
|
INTRODUCTION
Candida albicans is an important opportunistic fungal pathogen in human
which can cause mucosal and systemic infections (Bautiste-Muñoz
et al., 2003; Dendis et al., 2003; Karababa et al., 2004).
When immune system is weak (e.g., in immunocompromised patients as the result
of cancer chemotherapy or HIV infection) or when the competing flora are eliminated
(after antibiotic treatment), C. albicans colonizes and invades host
tissues (Warren and Hazen, 1995). The pathogen is the fourth most common hospital-acquired
infection in the United States, the treatment of which is estimated to cost
more than 1 billion $US annually. The genus Candida includes around 154
species that show different levels of resistance to antifungal agents. Consequently,
it is important to identify the causative organism to the species level correctly.
Identification of C. dubliniensis in particular, remains problematic
because of the high degree of phenotypic similarity between this species and
C. albicans (Neppelenbroek et al., 2005). Morphological features
and reproductive structures useful for identifying isolated yeasts may take
days to weeks to develop in culture and evaluation of these characteristics
requires expertise in mycology (Mirhendi et al., 2006). Molecular
techniques utilizing amplification of target DNA provide alternative methods
for diagnosis and identification of some organisms. Identification of Candida
species has been achieved by Restriction Fragment Length Polymorphism (RFLP)
analysis of the ribosomal DNA (rDNA) (Cirak et al., 2003).
At one study in China, a sensitive and speedy technique was established to identify
three medically important fungal species, Candida, Aspergillus
and Cryptococcus by using PCR-RFLP in vitro. The result showed
that PCR-RFLP is sensitive, specific and fast. Internal transcribed spacer1
(ITS1) and ITS2 and 5.8S rDNA were amplified by PCR and semi-nested PCR to detect
fungal DNA (Consuelo et al., 2001). Various techniques have
been reported to separate different fungi detected by universal primers, including
restriction fragment length polymorphism (Mirhendi et al.,
2001). Amplification Product Length Polymorphism (APLP) in PCR-APLP-RFLP assays
can be useful in the diagnosis of fungal infections in immunocompromised patients
It is documented that PCR-RFLP is sensitive, specific and fast method for detection
of the medically important fungi (Morace et al., 1997; Zhenyu et al.,
2000; Xu et al., 2002; Mirhendi et al., 2006). In this study,
using universal primers complementary to the coding regions of the fungal rRNA
genes, we amplified a 510 to 871 base pair segment of ITS1, 5.8S rRNA and ITS2
region from genomic DNAs of numerous isolates of the Candida species.
Restriction Enzyme Analysis (REA) of the PCR products allowed us to identify
most medically important Candida species including C. albicans,
C. tropicalis, C. glabrata and C. gilliermondii in 27 collected
samples from hospital referred vaginitis patients. This panel of PCR-restriction
enzyme analysis can be useful in diagnostic studies of Candida species
and Candidiasis and hence leading to proper treatment. This research was performed
in 2006 at the Department of Medical Parasitology and Mycology, College of Medicine,
Medical University of Kerman, Iran, Department of Plant Pathology and Biotechnology,
College of Agriculture, Bahonar University of Kerman and International Center
for Science and High Technology and Environmental Sciences, Mahan, Iran.
MATERIALS AND METHODS
Fungal isolates: Candida species were isolated from clinical specimens of vaginitis patients of Kashani and Afzalipoor hospitals who were submitted to the medical mycology laboratory. These samples were cultured on glucose 4%, peptone 1% and agar 1.5% and were incubated at 37°C for 2 days to develop proper growth for further studies.
DNA extraction: For DNA extraction, 300 μL of lysis buffer (10 mM Tris, 1 mM EDTA (pH 8), 1% SDS, 100 mM NaCl, 2% triton X-100), 300 μL of phenol-chloroform (1:1) solution and equal to 300 μL of 0.5 mm diameter glass beads, were added to yeast (Mirhendi et al., 2005). After 5 min of vigorous shaking which followed by 5 min centrifugation at 10000 rpm, the supernatant was isolated and transferred to a new tube and equal volume of chloroform was added, mixed gently, centrifuged and its supernatant was transferred to a new tube. For alcohol precipitation, 0.1 mL volume sodium acetate (pH 5.2) and 2.5 mL volume of cold absolute ethanol were added and the mixture was gently shaken and centrifuged at 10000 rpm for 10 min at 4°C. After washing with 70% ethanol, the pellet resuspended in 100 μL TE buffer (10 mM Tris, 1 mM EDTA) until it was used for PCR amplification.
PCR amplification: The PCR assay was performed with 1 μL of test sample (about 1 ng) in a total reaction volume of 50 μL, consisting of 10 mM Tris-HCl, 1.5 mM MgCl2, 50 mM KCl, 0.2 mM of each dATP, dCTP, dGTP and dTTP, 0.2 mM of each primers and 5U of Taq DNA polymerase. Thirty-five cycles of amplification were performed in a thermal cycler model Techne-progene.
After initial denaturation of DNA at 95°C for 5 min, each cycle consisted of a denaturation step at 94°C for 30s an extension step at 72°C for 1 min and a final extension step at 72°C for 7 min following the last cycle. After amplification, the samples were stored at -20°C before use. Appropriate negative controls were included in each test.
Restriction enzyme analyses: ITS1-ITS4 sequences of various Candida species were derived received from Mirhendi et al. (2006). On the basis of the sequences, the restriction sites of various restriction enzymes were determined by DNAsis software and the best enzymes were selected. For restriction digestion, 21.5 μL of PCR products were digested directly and individually by 10 U (1 μL) of the restriction enzyme MspI and 2.5 μL related buffer (total reaction of 25 μL) by 90 min incubation at 37°C.
Agarose gel electrophoresis: The resulting restriction fragments were analyzed by 2.5% agarose gel. Electrophoresis gel was conducted in TBE buffer (0.1 M Tris. 0.09 M boric acid, 20 mM EDTA, pH = 8, at 100 V for 45 min. The gel was stained with 0.5 μg mL-1 of ethidium bromide and photographed by Ultra Violet Photography (Integrated Vision Products®).
RESULTS
Using PCR-RFLP method, from the 27 tested samples, 22 identified as C.
albicans, 2 as C. glabrata, 2 as C. guilliermondii and 1
as C. tropicalis. The intergenic spacer regions of all tested isolates
were successfully amplified. The yeast-specific universal primer pairs generated
PCR products of approximately 510 to 871 bp related to different Candida
species. According to the results of the application of some enzymes on the
sequences of various Candida species (Mirhendi et al., 2006).
It was well conclusive that MspI is a suitable and useful restriction
enzyme for delineation of most important species of the yeast. The enzyme gave
two bands for each of C. albicans, C. tropicalis, C.
krusei and C. glabrata and three bands for C. guilliermondii (Mirhendi
et al., 2006). The produced bands were so well distinguishable
that none of mentioned Candida spp. were mistaken with each other. As
shown in Fig. 1 and 2, it is noticeable
that yeast isolates No. 19, 11, 24, 22, 29, 23, 25, 15 and 28 (Fig.
1) and No. 27, 14, 13, 30, 21 and 18 (Fig. 2) have 2 bands
around 338 bp and 297 bp which are indicative of C. albicans and the
isolates No. of 20 (Fig. 1) which is representative of C.
glabrata and 15 (Fig. 2) has 2 bands around 557 bp and
314 bp and isolate No. of 20 and 15 (Fig. 1 and 2)
are C. glabrata, 29 (Fig. 1) is C. tropicalis
and 17 (Fig. 2) is C. guilliermondii.
|
Fig. 1: |
Patterns of PCR products of Candida isolates after
digestion by the restriction enzyme MspI. Lanes of 19, 11, 24, 22,
29, 23, 25, 28 and 15 represent C. albicans; 20, C. glabrata
and 29, C. tropicalis. Lane M is 100 bp ladder molecular size
marker |
|
Fig. 2: |
Patterns of PCR products of Candida isolates after
digestion by the restriction enzyme MspI. Lanes of 27, 14, 30, 13,
21 and 18 represent C. albicans; 15, C. glabrata and 17,
C. guilliermondii. Lane M is 100 bp ladder molecular size marker
and C is negative control |
DISCUSSION
Rapid identification of Candida species in clinical laboratory is becoming
increasingly important as the incidence of Candidiasis continues to rise as
the hospital surveys indicate. Among the nosocomial bloodstream infections,
Candida species were ranked fourth hospital-wide. Candida species
were responsible for 10.2% of all cases of septicemia and 25% of all urinary
tract infections in intensive care units. On the other hand, the recent increase
in infections caused by non C. albicans species resistant to certain
antifungal drugs, C. dubliniensis has resulted in problems in the identification
of clinical samples (Dooley et al., 1994; Chavasco et al., 2006).
In a retrospective study carried out on a collection of yeasts, it was demonstrated
that 2% of the isolates originally identified as C. albicans were
actually C. dubliniensis (Soh, 2000). Making tests for rapid differentiation
of Candida species is valuable for targeted drug therapy (Birincia et
al., 2004; Mirhendi et al., 2005). The traditional methods of identification
of Candida species include laborious and subjective morphological and
assimilation tests that can take several days for identification (Consuelo et
al., 2001; Watton et al., 2004). Furthermore, microscopical tests
have been reported to misidentify clinical isolates (Dooley et al., 1994).
Restriction enzymes are endonucleases that cleave DNA in response to recognition
site on the DNA. The recognition site consists of a specific sequence of nucleotides
in the DNA duplex, typically 4-8 bp. Experiment with restriction enzyme is simple,
relatively inexpensive and their result is reproducible. These enzymes have
vast application in the molecular biology especially for the diagnostic purposes
(Mirhendi et al., 2005, 2006). Several DNA-based methods such as karyotyping,
DNA probing, DNA fingerprinting, restriction fragment length polymorphism analysis
and specific amplification of certain genes by the polymerase chain reaction
(PCR) have been used in the past to recognize species of the genus Candida
in clinical specimens (White et al., 2003; Mirhendi et al., 2006).
However, RAPD analysis is difficult to interpret and lacks reproducibility.
Furthermore, RFLP without a hybridization probe generally produces patterns
that are too dense and unresolved for computer analysis and hence it does not
lend itself to studies in which cluster analyses of moderately related isolates
are necessary (Soh, 2000; Bautiste-Muñoz et al., 2003). However,
most of these techniques mentioned above are actually able to differentiate
between Candida species other than C. albicans. Coding
regions of the 18s, 5.8s and 28s nuclear rRNA genes evolve slowly and so are
good candidates, since they are present in high copy number and the sensitivity
of their detection may be dramatically increased by the use of nested PCR (Cirak
et al., 2003) and relatively conserved among fungi providing a molecular
basis of establishing phylogenetic relationship. Identification of rDNA genes
has been used to identify pathogenic fungi (Baere et al., 2002). Sequence
variability of the internal transcribed spacer 2 (ITS2) region of fungi is potentially
useful in rapid and accurate diagnosis of clinical fungal isolates. PCR with
fungus-specific primers targeted toward conserved sequences of the 5.8 and 28S
ribosomal DNA (rDNA) results in amplification of the species-specific ITS2 regions,
which are variable in amplicon length (Turenne et al., 1999). Thus PCR
amplification may facilitate the identification of its region DNA sequences
with sufficient polymorphism to be used for identifying fungal species especially
Candida species (Berman and Sudbery, 2002). We like to express that these
enzymes and technique has been used previously by Mirhendi et al. (2006)
which their results comprehend with ours coherently. The overall conclusion
of our PCR-restriction enzyme analysis is that this procedure can be used as
diagnostic and differentiating tool about the Candida species and Candidiasis
which would lead to more accurate medical treatment of the patient malady.
ACKNOWLEDGMENTS
Kind cooperation of Dr. Mirhendi from Department of Medical Parasitology and Mycology, School of Public Health and Institute of Public Health Researchs (Isfahan Center) and Department of Medical Parasitology and Mycology, College of Medicine, Medical University of Kerman is appreciated. This research is dedicated to Mrs. Fakhereh Saba and Mr. Ali Reza Afzalipour, the founders of Universities in Kerman.
|
REFERENCES |
1: Baere, T., G. Glaeys, D. Swine, C. Massonet, G. Verschraegen, A. Muylaert and M. Vaneechoutte, 2002. Identification of cultured isolates of clinically important yeast species using fluorescent fragment length analysis of the amplified internally transcribed rRNA spacer 2 regions (ITS2). BMC Microbiol., 2: 21-25. Direct Link |
2: Bautista-Munoz, C., X.M. Boldo, L.V. Tanaca and C. Hernandez-Rodriguez, 2003. Identification of Candida spp. by randomly amplified polymorphic DNA analysis and differentiation between Candida albicans and Candida dubliniensis by direct PCR methods. J. Clin. Microbiol., 41: 414-420. CrossRef | Direct Link |
3: Berman, J. and P.E. Sudbery, 2002. Candida albicans: A molecular revolution built on lessons from budding yeast. Nature Rev., 3: 918-932. CrossRef | Direct Link |
4: Birincia, A., S. Akkurt and C. Acuner, 2004. Rapid identification of Candida species from direct blood culture by CHROMagar. J. Int. Med. Res., 32: 484-487.
5: Chavasco, J.K., C.R. Paulaq and M.K. Hirata, 2006. Molecular identification of Candida dubliniensis isolated from oral lesions of HIV-positive and HIV-negative patients in Sao Paulo, Brazil. Rev. Inst. Med. Trop., 48: 21-26. Direct Link |
6: Cirak, M.Y., A. Kalkanci and S. Kustimur, 2003. Use of molecular methods in identification of Candida species and evolution of fluconazole resistance. Mem. Inst. Oswaldo Cruz., 98: 1027-1032. Direct Link |
7: Consuelo, F., F. Colom and S. Frases, 2001. Detection and identification of fungal pathogens by PCR and by ITS2 and 5.8S ribosomal DNA typing in ocular infections. J. Clin. Microbiol., 39: 2873-2879. Direct Link |
8: Dendis, M., R. Horvath, J. Michalek, F. Ruzicka, M. Grijalva, M. Bartos and J. Benedik, 2003. PCR-RFLP detection and species identification of fungal pathogens in patients with febrile neutropenia. Clin. Microbiol. Infect., 9: 1191-1202. Direct Link |
9: Dooley, D.P., M.L. Beckius and B.S. Jeffrey, 1994. Misidentification of clinical yeast isolates by using the updated vitek yest biochemical card. J. Clin. Microbiol., 32: 2889-2892. Direct Link |
10: Karababa, M., A.T. Coste, B. Rognon, J. Bille and D. Sanglard, 2004. Comparison of gene expression profiles of Candida albicans azole-resistant clinical isolates and laboratory strains exposed to drugs indusing multidrug transporters. Antimicrob. Agen. Chemother., 48: 3064-3079. Direct Link |
11: Mirhendi, S.H., P. Kordbacheh, B. Kazemi, S. Samiei, M. Pezeshki and M.R. Khorramizadeh, 2001. A PCR-RFLP method to identification of the important opportunistic fungi: Candida species, Cryptococcus neoformans, Aspergillus fumigatus and Fusarium solani. Iran. J. Publ. Health, 30: 103-106. Direct Link |
12: Mirhendi, H., L. Makimura, K. Zomorodian, N. Maeda, T. Ohshima and H. Yamaguchi, 2005. Differentiation of Candida albicans and Candida dubliniensis using a single-enzyme PCR-RFLP methods. Jap. J. Infect. Dis., 58: 235-237. Direct Link |
13: Mirhendi, S.H., K. Makimura, M. Khoramizadeh and H. Yamaguchi, 2006. A one-enzyme PCR-RFLP assay for identification of six medically important Candida species. Jap. J. Med. Mycol., 47: 225-229. Direct Link |
14: Morace, G., M. Sanguinetti, B. Posteraro, G. Cascio and G. Fadda, 1997. Identification of various medically important Candida species in clinical specimens by PCR-restriction enzyme. J. Clin. microbiol., 35: 667-672. Direct Link |
15: Neppelenbroek, K.H., N.H. Campanha, D.M. Spolidorio, L.C. Spolidorio, R.S. Seo and A.C. Pavarina, 2005. Molecular fingerprinting methods for the discrimination between C. albicans and C. dubliniensis. Oral Dis., 12: 242-253. PubMed |
16: Soll, D.R., 2000. The ins and outs of DNA fingerprinting the infectious fungi. Clin. Microbiol. Rev., 13: 332-370. CrossRef | Direct Link |
17: Turenne, C.Y., S.E. Sanche, D.J. Hoban, J.A. Karlowsky and A.M. Kabani, 1999. Rapid identification of fungi by using the ITS2 genetic region and an automated fluorescent capillary electrophoresis system. J. Clin. Microbiol., 37: 1846-1851. Direct Link |
18: Warren, N.G.M. and R.C. Hazen, 1995. Candida, Cryptococcus and other Yeast of Medical Importance. In: Manual of Clinical Microbiology, Murray, R.P., E.J. Baron, M.A.P. Faller, F.C. Tenover and K.H. Yolen (Eds.). 6th Edn. ASM, Washington DC
19: Watton, D., K. Reece and T. Bittner, 2004. Comparison between rep-PCR-based DNA fingerprint and ITS1-ITS2 sequence analysis of clinically important Candida species. American Society for Microbiology Conference on Candida and Candidiasis.
20: White, P.C., A. Shetly and R.A. Barnes, 2003. Detection of seven Candida species using the light-cycler system. J. Med. Microbial., 52: 229-238. Direct Link |
21: Xu, J., B.C. Millar, J.E. Molre and R. Mcmullan, 2002. Comparison of API20C with molecular identification of Candida spp. isolated from blood stream infections. J. Clin. Pathol., 52: 774-777. Direct Link |
22: Zhenyu, Q., W. Shaoxi, L. Guixia, R.L. Hopfer, Z. Hong and G. Ningru, 2000. Identification of Candida, Aspergillus and Cryptococcus by using PCR- RFLP. J. Clin. Dermatol., 29: 76-78.
|
|
|
 |